Pharmasset (VRUS) Posts Mixed Q211 Results; Loss Narrower than Expected
Tweet
Share
E-mailGet Alerts VRUS Hot Sheet
Join SI Premium – FREE
Pharmasset, Inc. (Nasdaq: VRUS) reported Q2 loss of $0.55, $0.10 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $247 thousand versus the consensus estimate of $440 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
- Aptera Motors (SEV) Reports Q2 Loss of $0.20
- Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
